 | Up a level |
Sava, Mihaela; Sommer, Gregor; Daikeler, Thomas; Woischnig, Anne-Kathrin; Martinez, Aurelien E; Leuzinger, Karoline; Hirsch, Hans H.; Erlanger, Tobias; Wiencierz, Andrea; Bassetti, Stefano; Tamm, Michael; Tschudin-Sutter, Sarah; Stoeckle, Marcel; Pargger, Hans; Siegemund, Martin; Boss, Renate; Zimmer, Gert; Vu, Diem-Lan; Kaiser, Laurent; Dell-Kuster, Salome; ... (2021). Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss medical weekly, 151(w20550), w20550. EMH Media 10.4414/smw.2021.20550
Walti, Laura N.; Mugglin, Catrina; Sidler, Daniel; Mombelli, Matteo; Manuel, Oriol; Hirsch, Hans H.; Khanna, Nina; Mueller, Nicolas; Berger, Christoph; Boggian, Katia; Garzoni, Christian; Neofytos, Dionysios; van Delden, Christian; Hirzel, Cédric; Transplant Cohort Study Stcs, Swiss (2021). Association of Antiviral Prophylaxis and Rituximab Use with Post-transplant Lymphoproliferative Disorders (PTLD): A Nationwide Cohort Study. American journal of transplantation, 21(7), pp. 2532-2542. Wiley-Blackwell 10.1111/ajt.16423
Metzner, Karin J.; Scherrer, Alexandra U.; Von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Hirsch, Hans H.; Vernazza, Pietro L.; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F. (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15), pp. 2231-2239. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000397
Hirsch, Hans H.; Mohaupt, Markus; Klimkait, Thomas (2001). Prospective Monitoring of BK Virus Load after Discontinuing Sirolimus Treatment in a Renal Transplant Patient with BK Virus Nephropathy. Journal of infectious diseases, 184(11), pp. 1494-1495. The University of Chicago Press 10.1086/324425
